All In Biotech

Drug Trial Radar · NCT06962865

A Phase Ⅱ Study of RC108 in Combination With Furmonertinib for the First-line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

A Randomized, Open, Controlled, Multicenter Phase II Clinical Study of RC108 in Combination With Furmonertinib Versus Furmonertinib for the First-Line Treatment of EGFR-Mutated Combined MET-Positive Unresectable Locally Advanced or Recurrent Metastatic NSCLC

Last checked: Nov 19, 2026Latest source record: Jul 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Jun 30, 2025

Primary completion

May 31, 2026

Study completion Dec 31, 2027

Sponsor

Lead sponsor
RemeGen Co., Ltd.Industry
Sponsor type
Industry
First posted
May 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the efficacy and safety of RC108 in combination with Furmonertinib against Furmonertinib for treatment of EGFR mutation combined with MET-positive unresectable locally advanced or recurrent metastatic NSCLC

Conditions

  • Non-Small Cell Lung Cancer

Interventions

  • RC108Drug

    RC108 in Combination With Furmonertinib

  • Furmonertinib Mesilate Tablets MonotherapyDrug

    Furmonertinib

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate (ORR)Time frame: 24 months

Locations

34 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Chest Hospital,Capital Medical Unniversity

    Beijing, China · Recruiting

  • The Fifth Medical Center of Chinese People's Liberation Army General Hospital

    Beijing, China · Recruiting

  • Binzhou Medical University Hospital

    Binzhou, China · Recruiting

  • Jilin Cancer Hospital

    Changchun, China · Recruiting

  • The Second Xiangya Hospital Of Central South University

    Changsha, China · Recruiting

  • Changzhou Cancer Hospital

    Changzhou, China · Recruiting

  • Sichuan Cancer Hospital

    Chengdu, China · Recruiting

  • West China hospitial of SiChuan University

    Chengdu, China · Recruiting

  • Chongqing University Cancer Hospitai

    Chongqing, China · Recruiting

  • Fujian Cancer Hospital

    Fuzhou, China · Recruiting

  • Ganzhou cancer Hospitial

    Ganzhou, China · Recruiting

  • Affiliated Cancer Hospital of Guangzhou Medical University

    Guangzhou, China · Recruiting

  • The First Affiliated Hospital of Wenzhou Medical University

    Guilin, China · Recruiting

  • The Second Affiliated Hospital of Guilin Medical University

    Guilin, China · Recruiting

  • Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

    Hangzhou, China · Recruiting

  • Harbin Medical University Cancer Hospital

    Harbin, China · Recruiting

  • Anhui Provincial cancer hospital

    Hefei, China · Recruiting

  • The First hospitial of Anhui Medicine University

    Hefei, China · Recruiting

  • Jinan Central Hospital

    Jinan, China · Recruiting

  • Shandong Cancer Hospital

    Jinan, China · Recruiting

  • The First hospitial of Lanzhou University

    Lanzhou, China · Recruiting

  • Linyi People's Hospital

    Linyi, China · Recruiting

  • THE FIRST HOSPITAI OF CHINA MEDICAL UNIVERSITY,No. 155, Nanjing North Street, Heping District, Shenyang City, Liaoning Province

    Shenyang, China · Recruiting

  • The Fourth Hospital of Hebei Medical University

    Shijiazhuang, China · Recruiting

  • Shanxi Cancer Hospital

    Taiyuan, China · Recruiting

  • Taizhou hospitial of Zhejiang province

    Taizhou, China · Recruiting

  • Tianjin Chest Hospital

    Tianjin, China · Recruiting

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, China · Recruiting

  • Xiangyang Central Hospital

    Xiangyang, China · Recruiting

  • The Second People's Hospital of Yibin City

    Yibin, China · Recruiting

  • Yiyang Central Hospital

    Yiyang, China · Recruiting

  • Yueyang Central Hospital

    Yueyang, China · Recruiting

  • Yunnan Cancer Hospital

    Yunnan, China · Recruiting

  • The First Affiliated Hospital of Zhengzhou University

    Zhengzhou, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.